{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T05:12:21Z","timestamp":1731647541374,"version":"3.28.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,13]]},"DOI":"10.7759\/cureus.73642","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T06:03:41Z","timestamp":1731564221000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-Cell Lymphoma Presenting With Hypercalcemia"],"prefix":"10.7759","author":[{"given":"Yasser","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Tien Aaron","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ghallab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8933-21","article-title":"Hypercalcemia associated with the ectopic expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in diffuse large B-cell lymphoma","volume":"61","author":"Ogawa M","year":"2022","unstructured":"Ogawa M, Morikawa M, Kobatake M, et al.. Hypercalcemia associated with the ectopic expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in diffuse large B-cell lymphoma. Intern Med. 2022, 61:2489-95. 10.2169\/internalmedicine.8933-21","journal-title":"Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1241821","article-title":"Hypercalcemia in cancer patients: pathobiology and management","volume":"42","author":"Santarpia L","year":"2010","unstructured":"Santarpia L, Koch CA, Sarlis NJ. Hypercalcemia in cancer patients: pathobiology and management. Horm Metab Res. 2010, 42:153-64. 10.1055\/s-0029-1241821","journal-title":"Horm Metab Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.749","article-title":"Prevalence of hypercalcemia among cancer patients in the United States","volume":"5","author":"Gastanaga VM","year":"2016","unstructured":"Gastanaga VM, Schwartzberg LS, Jain RK, et al.. Prevalence of hypercalcemia among cancer patients in the United States. Cancer Med. 2016, 5:2091-100. 10.1002\/cam4.749","journal-title":"Cancer Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart AF","year":"2005","unstructured":"Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005, 352:373-9. 10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1620946","article-title":"Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma","volume":"60","author":"Abadi U","year":"2019","unstructured":"Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U. Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma. Leuk Lymphoma. 2019, 60:2922-6. 10.1080\/10428194.2019.1620946","journal-title":"Leuk Lymphoma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.170600","article-title":"Hypercalcemia of malignancy: an update on pathogenesis and management","volume":"7","author":"Mirrakhimov AE","year":"2015","unstructured":"Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. N Am J Med Sci. 2015, 7:483-93. 10.4103\/1947-2714.170600","journal-title":"N Am J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-1-1","article-title":"Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma","volume":"100","author":"Breslau NA","year":"1984","unstructured":"Breslau NA, McGuire JL, Zerwekh JE, Frenkel EP, Pak CY. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med. 1984, 100:1-6. 10.7326\/0003-4819-100-1-1","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5101-6_24","article-title":"The metabolism and functions of vitamin D","volume":"196","author":"DeLuca HF","year":"1986","unstructured":"DeLuca HF. The metabolism and functions of vitamin D. Adv Exp Med Biol. 1986, 196:361-75. 10.1007\/978-1-4684-5101-6_24","journal-title":"Adv Exp Med Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2735","article-title":"Hypercalcemia at diagnosis of diffuse large B-cell lymphoma is not uncommon and is associated with high-risk features and a short diagnosis-to-treatment interval","volume":"38","author":"Gauchy AC","year":"2020","unstructured":"Gauchy AC, Kanagaratnam L, Quinquenel A, et al.. Hypercalcemia at diagnosis of diffuse large B-cell lymphoma is not uncommon and is associated with high-risk features and a short diagnosis-to-treatment interval. Hematol Oncol. 2020, 38:326-33. 10.1002\/hon.2735","journal-title":"Hematol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.5198","article-title":"Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials","volume":"36","author":"Maurer MJ","year":"2018","unstructured":"Maurer MJ, Ghesqui\u00e8res H, Link BK, et al.. Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials. J Clin Oncol. 2018, 36:1603-10. 10.1200\/JCO.2017.76.5198","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82615-4","article-title":"Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma","volume":"11","author":"Yoshida M","year":"2021","unstructured":"Yoshida M, Nakaya Y, Shimizu K, et al.. Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma. Sci Rep. 2021, 11:2837. 10.1038\/s41598-021-82615-4","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/310356-diffuse-large-b-cell-lymphoma-presenting-with-hypercalcemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T06:03:42Z","timestamp":1731564222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/310356-diffuse-large-b-cell-lymphoma-presenting-with-hypercalcemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.73642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}